港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

藥明合聯

61.150

-0.550-0.89%

成交量：506.30萬

成交額：3.11億

市值：769.27億

市盈率：48.09

高：62.550

開：62.400

低：60.300

收：61.700

52周最高：85.500

52周最低：24.700

股本：12.58億

香港流通股本：12.58億

量比：0.82

換手率：0.40%

股息：- -

股息率：- -

每股收益(LYR):1.272

淨資產收益率：17.05%

總資產收益率：8.60%

市淨率：6.32

市盈率(LYR):48.09

市銷率: 11.40

資料載入中...

總覽公司新聞資訊公告

大摩：藥明合聯(02268)股價未來30日將絕對上漲

智通财经网

醫藥行業跟蹤報告：中國創新ADC閃耀ASCO GU，長效三靶點減肥藥二期臨床成功

每日沽空追蹤 | 藥明合聯 03月02日沽空量成交30.3萬股，沽空比例為6.7%

【券商聚焦】招銀國際：AI將改變創新藥物研發範式

《大行》交銀國際：藥明合聯(02268.HK)全球CXO賽道投融資、BD交易延續高活躍度維持「買入」評級

阿斯达克财经

《大行》大摩：藥明合聯(02268.HK)股價未來30日將絕對上漲

阿斯达克财经

藥明合聯與Earendil Labs就Wuxitecan-2有效載荷-連接子技術平台達成戰略合作

藥明合聯與Earendil Labs就WuXiTecan-2載荷連接子技術授權達成戰略合作

藥明合聯午前漲近8% 公司有望持續受益XDC CRDMO行業下游需求改善趨勢

【券商聚焦】交銀國際：2026年醫藥板塊穩中向好態勢或將延續但仍有短期波動可能

【券商聚焦】交銀國際維持藥明合聯(02268)買入評級指XDC賽道融資/BD開年延續較高熱情

港股創新藥概念股走強！藥明合聯升逾7%，雲頂新耀、再鼎醫藥漲近6%

老虎资讯综合

藥明合聯02月26日主力淨流出958.1萬元散户資金買入

藥明合聯盤中異動大幅跳水5.01%報60.700港元

每日沽空追蹤 | 藥明合聯 02月25日沽空量成交32.9萬股，沽空比例為16.42%

每日沽空追蹤 | 藥明合聯 02月23日沽空量成交11.3萬股，沽空比例為10.52%

【國聯民生醫藥】醫藥周報20260223：春節期間醫藥行業重點事件梳理

医耀科技创新骑手

《大行》大摩降藥明合聯(02268.HK)目標價至86元評級「增持」

阿斯达克财经

藥明合聯(02268)出現大手賣出11.95萬股，成交價$64.95，涉資776.152萬

阿斯达克财经

藥明合聯02月16日遭主力拋售211.9萬元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02268/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02268","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"藥明合聯","latestPrice":61.15,"timestamp":1775117301004,"preClose":61.7,"halted":0,"volume":5063015,"delay":0,"changeRate":-0.008914100486223731,"floatShares":1258000000,"shares":1258000000,"eps":1.271544747431366,"marketStatus":"已收盤","change":-0.55,"latestTime":"04-02 16:08:21","open":62.4,"high":62.55,"low":60.3,"amount":310598368,"amplitude":0.036467,"askPrice":61.25,"askSize":1000,"bidPrice":61.15,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":1.2696567288572616,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1775611800000},"marketStatusCode":5,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":61.7,"openAndCloseTimeList":[[1775093400000,1775102400000],[1775106000000,1775116800000]],"volumeRatio":0.818522,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","floatShares":1258000000,"roa":"8.60%","roe":"17.05%","lyrEps":1.271545,"volumeRatio":0.818522,"shares":1258000000,"dividePrice":0,"high":62.55,"amplitude":0.036467,"preClose":61.7,"low":60.3,"week52Low":24.7,"pbRate":"6.32","psRate":"11.40","week52High":85.5,"institutionHeld":0,"latestPrice":61.15,"committee":0.428571,"eps":1.271544747431366,"divideRate":0,"volume":5063015,"delay":0,"ttmEps":1.2696567288572616,"open":62.4,"prevYearClose":60.75,"prevWeekClose":58.9,"prevMonthClose":58.2,"prevQuarterClose":58.2,"fiveDayClose":56.15,"twentyDayClose":57.65,"sixtyDayClose":63.4,"earningDate":1777392000000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02268\",params:#limit:5,,,undefined,":[{"date":"2026-04-29","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1777426200000,"name":null,"time":"","dateTimestamp":1777392000000,"actualEps":null},{"date":"2026-03-23","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-18","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-20","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724117400000,"name":null,"time":"","dateTimestamp":1724083200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02268\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02268\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.7143,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":21,"updateTime":1774627200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02268\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02268","date":"2026-04-01","current":48.143681,"percent":0.219178,"low":30.568632,"twenty":44.673253,"median":58.208228,"eighty":71.283766,"high":153.052589,"avg":63.722291,"sd":26.112995,"marketCap":77618149898},"quantilePoints":[{"date":"2023-11-17","current":130.035431,"twenty":0.435785,"median":0.444801,"eighty":2.787891,"marketCap":32996488000},{"date":"2023-11-24","current":133.579843,"twenty":0.435785,"median":0.444801,"eighty":2.810425,"marketCap":34174934000},{"date":"2023-12-01","current":147.707211,"twenty":0.435785,"median":0.444801,"eighty":2.852893,"marketCap":37945961200},{"date":"2023-12-08","current":132.646927,"twenty":0.435785,"median":0.444801,"eighty":2.935117,"marketCap":33939244800},{"date":"2023-12-15","current":138.75437,"twenty":0.435785,"median":0.444801,"eighty":3.039251,"marketCap":35706913800},{"date":"2023-12-22","current":153.052589,"twenty":0.435785,"median":0.444801,"eighty":3.172504,"marketCap":39360096400},{"date":"2023-12-29","current":145.85951,"twenty":0.435785,"median":0.444801,"eighty":3.326638,"marketCap":37710272000},{"date":"2024-01-05","current":142.305018,"twenty":0.435785,"median":0.444801,"eighty":3.599996,"marketCap":36531826000},{"date":"2024-01-12","current":138.558869,"twenty":0.435785,"median":0.444801,"eighty":3.622774,"marketCap":35589069200},{"date":"2024-01-19","current":141.046625,"twenty":0.435785,"median":0.444801,"eighty":3.635946,"marketCap":36178292200},{"date":"2024-01-26","current":116.23004,"twenty":0.435785,"median":0.444801,"eighty":3.642902,"marketCap":29696839200},{"date":"2024-02-02","current":82.111439,"twenty":0.435785,"median":0.444801,"eighty":3.654128,"marketCap":20952769880},{"date":"2024-02-09","current":67.278987,"twenty":0.435825,"median":0.445043,"eighty":3.68657,"marketCap":17252449440},{"date":"2024-02-16","current":66.713097,"twenty":0.435798,"median":0.44487,"eighty":3.704054,"marketCap":17111035920},{"date":"2024-02-23","current":82.124312,"twenty":0.435798,"median":0.44487,"eighty":3.728385,"marketCap":20952769880},{"date":"2024-03-01","current":86.135235,"twenty":0.435812,"median":0.444939,"eighty":3.767614,"marketCap":21989802360},{"date":"2024-03-08","current":96.662972,"twenty":0.435812,"median":0.444939,"eighty":3.804363,"marketCap":24688443700},{"date":"2024-03-15","current":72.134287,"twenty":0.435812,"median":0.444939,"eighty":3.87411,"marketCap":18407326520},{"date":"2024-03-22","current":82.739174,"twenty":0.435812,"median":0.444939,"eighty":3.907844,"marketCap":21094183400},{"date":"2024-03-28","current":70.236298,"twenty":0.435812,"median":0.444939,"eighty":3.924107,"marketCap":21565561800},{"date":"2024-04-05","current":69.514463,"twenty":0.435772,"median":0.444721,"eighty":3.932321,"marketCap":21329872600},{"date":"2024-04-12","current":72.929575,"twenty":0.435785,"median":0.444801,"eighty":3.970214,"marketCap":22390474000},{"date":"2024-04-19","current":66.691535,"twenty":0.435785,"median":0.444801,"eighty":4.01279,"marketCap":20457822560},{"date":"2024-04-26","current":78.851628,"twenty":0.435812,"median":0.444939,"eighty":62.837086,"marketCap":24158143000},{"date":"2024-05-03","current":79.483533,"twenty":0.435812,"median":0.444939,"eighty":66.70016,"marketCap":24334909900},{"date":"2024-05-10","current":73.189732,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":22461180760},{"date":"2024-05-17","current":65.221538,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19986444160},{"date":"2024-05-24","current":58.278715,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17818103520},{"date":"2024-05-31","current":59.948577,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":18347300940},{"date":"2024-06-07","current":58.299117,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17820354960},{"date":"2024-06-14","current":64.156468,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19592809620},{"date":"2024-06-21","current":70.500097,"twenty":0.435812,"median":0.444939,"eighty":69.593748,"marketCap":21485024730},{"date":"2024-06-28","current":68.013259,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":20718557850},{"date":"2024-07-05","current":61.893714,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":18850294830},{"date":"2024-07-12","current":63.530585,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":19377240810},{"date":"2024-07-19","current":56.933019,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17365265250},{"date":"2024-07-26","current":56.800526,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17389217340},{"date":"2024-08-02","current":69.358964,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":21221551740},{"date":"2024-08-09","current":72.710245,"twenty":0.435812,"median":0.444939,"eighty":70.597189,"marketCap":22395204150},{"date":"2024-08-16","current":74.003491,"twenty":0.435812,"median":0.444939,"eighty":70.930659,"marketCap":22802389680},{"date":"2024-08-23","current":35.050376,"twenty":0.435812,"median":0.44524,"eighty":71.736965,"marketCap":22742129354},{"date":"2024-08-30","current":36.779427,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":24024219892},{"date":"2024-09-06","current":36.193339,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":23652773101},{"date":"2024-09-13","current":36.950123,"twenty":0.435812,"median":0.445611,"eighty":71.736965,"marketCap":24084130665},{"date":"2024-09-20","current":36.912594,"twenty":0.435798,"median":0.445732,"eighty":71.812082,"marketCap":24203952211},{"date":"2024-09-27","current":41.596291,"twenty":0.435798,"median":0.446064,"eighty":71.812082,"marketCap":27439133942},{"date":"2024-10-04","current":49.267448,"twenty":0.435798,"median":0.446181,"eighty":71.812082,"marketCap":32351817312},{"date":"2024-10-10","current":43.61955,"twenty":0.435812,"median":0.446472,"eighty":71.736965,"marketCap":28457617080},{"date":"2024-10-18","current":43.201999,"twenty":0.435798,"median":0.446694,"eighty":71.812082,"marketCap":28038241670},{"date":"2024-10-25","current":43.020102,"twenty":0.435798,"median":0.446852,"eighty":71.812082,"marketCap":27918420124},{"date":"2024-11-01","current":41.699543,"twenty":0.435798,"median":0.446999,"eighty":71.812082,"marketCap":27079669305},{"date":"2024-11-08","current":47.130705,"twenty":0.435852,"median":0.447279,"eighty":71.812082,"marketCap":30374761809},{"date":"2024-11-15","current":46.740281,"twenty":0.435852,"median":0.44753,"eighty":71.812082,"marketCap":29895475627},{"date":"2024-11-22","current":46.01742,"twenty":0.435852,"median":0.447785,"eighty":71.812082,"marketCap":29416189444},{"date":"2024-11-29","current":51.670123,"twenty":0.435852,"median":0.448371,"eighty":71.812082,"marketCap":33010835812},{"date":"2024-12-06","current":54.048034,"twenty":0.435852,"median":0.449445,"eighty":71.812082,"marketCap":34448694360},{"date":"2024-12-13","current":58.707371,"twenty":0.435852,"median":0.45138,"eighty":71.812082,"marketCap":37384322227},{"date":"2024-12-20","current":60.54506,"twenty":0.435852,"median":35.016583,"eighty":71.812082,"marketCap":38342894592},{"date":"2024-12-27","current":58.22519,"twenty":0.435852,"median":35.863906,"eighty":71.812082,"marketCap":36845125272},{"date":"2025-01-03","current":57.033249,"twenty":0.435852,"median":36.241161,"eighty":71.812082,"marketCap":36126195998},{"date":"2025-01-10","current":62.66188,"twenty":0.435852,"median":36.730689,"eighty":71.812082,"marketCap":39541110048},{"date":"2025-01-17","current":54.642634,"twenty":0.436361,"median":37.212991,"eighty":71.812082,"marketCap":34508605132},{"date":"2025-01-24","current":54.868028,"twenty":0.436606,"median":39.470644,"eighty":71.812082,"marketCap":34868069769},{"date":"2025-01-28","current":52.331181,"twenty":0.436643,"median":41.238065,"eighty":71.736965,"marketCap":33430211222},{"date":"2025-02-07","current":57.910706,"twenty":0.437089,"median":42.380717,"eighty":71.8872,"marketCap":36785214499},{"date":"2025-02-14","current":56.82028,"twenty":0.437089,"median":43.020102,"eighty":71.8872,"marketCap":36006374452},{"date":"2025-02-21","current":70.802488,"twenty":0.437089,"median":44.139364,"eighty":71.8872,"marketCap":45112811918},{"date":"2025-02-28","current":60.65941,"twenty":0.437089,"median":45.078416,"eighty":71.8872,"marketCap":38522626910},{"date":"2025-03-07","current":67.088057,"twenty":0.437583,"median":46.607669,"eighty":71.962317,"marketCap":42776291779},{"date":"2025-03-14","current":72.98104,"twenty":0.438098,"median":47.703312,"eighty":71.990989,"marketCap":46550670465},{"date":"2025-03-21","current":80.244903,"twenty":0.438098,"median":49.592986,"eighty":72.978175,"marketCap":51163799971},{"date":"2025-03-28","current":47.906694,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":54840613248},{"date":"2025-04-03","current":43.121995,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":49380552191},{"date":"2025-04-11","current":35.581021,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":40380451549},{"date":"2025-04-17","current":33.597127,"twenty":0.4381,"median":49.700845,"eighty":72.980467,"marketCap":38220427395},{"date":"2025-04-25","current":39.226609,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44663120338},{"date":"2025-05-02","current":40.829264,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":46586700218},{"date":"2025-05-09","current":38.818219,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44603008467},{"date":"2025-05-16","current":39.608151,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":45882474676},{"date":"2025-05-23","current":38.196121,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44379117053},{"date":"2025-05-30","current":41.172242,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":48047309655},{"date":"2025-06-06","current":42.866418,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":50152010328},{"date":"2025-06-13","current":46.041552,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":53888090995},{"date":"2025-06-20","current":41.240748,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":48174509918},{"date":"2025-06-27","current":40.971553,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":47994081042},{"date":"2025-07-04","current":46.000985,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":53888090995},{"date":"2025-07-11","current":47.288014,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":55339986740},{"date":"2025-07-18","current":50.925924,"twenty":0.438098,"median":50.569275,"eighty":72.98104,"marketCap":59550637905},{"date":"2025-07-25","current":57.660678,"twenty":0.438098,"median":51.683826,"eighty":72.98104,"marketCap":67671179437},{"date":"2025-08-01","current":57.245588,"twenty":0.438098,"median":52.545804,"eighty":72.98104,"marketCap":66768897045},{"date":"2025-08-08","current":57.73965,"twenty":0.43811,"median":53.257543,"eighty":72.98104,"marketCap":67513611340},{"date":"2025-08-15","current":64.222783,"twenty":31.309336,"median":54.856958,"eighty":72.98104,"marketCap":74981664691},{"date":"2025-08-22","current":48.130228,"twenty":34.419063,"median":54.952855,"eighty":72.98104,"marketCap":69501077151},{"date":"2025-08-29","current":46.988345,"twenty":35.581021,"median":54.952855,"eighty":72.98104,"marketCap":68176099944},{"date":"2025-09-05","current":54.370406,"twenty":36.186031,"median":55.113399,"eighty":72.98104,"marketCap":78808670381},{"date":"2025-09-12","current":57.034752,"twenty":36.596757,"median":55.50873,"eighty":72.98104,"marketCap":82819396110},{"date":"2025-09-19","current":59.571504,"twenty":36.911418,"median":56.000464,"eighty":72.98104,"marketCap":86441593568},{"date":"2025-09-26","current":63.204858,"twenty":37.279949,"median":56.495601,"eighty":72.98104,"marketCap":91475834102},{"date":"2025-10-03","current":72.025865,"twenty":37.670679,"median":56.699916,"eighty":72.980467,"marketCap":104491187679},{"date":"2025-10-10","current":60.90024,"twenty":38.189538,"median":56.97042,"eighty":72.98104,"marketCap":88221995708},{"date":"2025-10-17","current":57.936353,"twenty":38.732076,"median":57.121577,"eighty":72.98104,"marketCap":83863080123},{"date":"2025-10-24","current":59.821834,"twenty":39.226609,"median":57.526112,"eighty":72.98104,"marketCap":86623810506},{"date":"2025-10-31","current":63.630196,"twenty":39.774995,"median":57.92353,"eighty":72.98104,"marketCap":92275860553},{"date":"2025-11-07","current":58.827143,"twenty":40.354886,"median":58.251953,"eighty":72.98104,"marketCap":85257233036},{"date":"2025-11-14","current":59.953959,"twenty":41.172242,"median":58.455089,"eighty":72.98104,"marketCap":87136525462},{"date":"2025-11-21","current":57.356344,"twenty":41.596291,"median":58.554061,"eighty":72.98104,"marketCap":83322340564},{"date":"2025-11-28","current":56.291024,"twenty":42.018405,"median":58.564991,"eighty":72.98104,"marketCap":82071768197},{"date":"2025-12-05","current":57.95451,"twenty":42.42494,"median":58.564991,"eighty":72.98104,"marketCap":84642388897},{"date":"2025-12-12","current":56.819112,"twenty":42.866418,"median":58.860686,"eighty":72.98104,"marketCap":83137635317},{"date":"2025-12-19","current":59.902097,"twenty":43.024716,"median":58.930609,"eighty":72.98104,"marketCap":87855221510},{"date":"2025-12-24","current":53.787136,"twenty":43.211711,"median":58.930609,"eighty":72.98104,"marketCap":79132453088},{"date":"2026-01-02","current":52.131715,"twenty":43.875774,"median":58.940897,"eighty":73.022778,"marketCap":76998826280},{"date":"2026-01-09","current":60.097118,"twenty":44.079539,"median":58.920321,"eighty":72.979321,"marketCap":88984788643},{"date":"2026-01-16","current":59.868148,"twenty":44.329264,"median":59.011667,"eighty":72.978748,"marketCap":88933823858},{"date":"2026-01-23","current":58.064858,"twenty":44.542103,"median":59.011667,"eighty":72.978748,"marketCap":86172293688},{"date":"2026-01-30","current":52.991062,"twenty":44.673253,"median":58.945496,"eighty":72.939295,"marketCap":79001941874},{"date":"2026-02-06","current":53.067413,"twenty":44.72485,"median":58.907275,"eighty":72.769063,"marketCap":79316440050},{"date":"2026-02-13","current":54.647287,"twenty":44.764796,"median":58.707371,"eighty":72.713983,"marketCap":82146923636},{"date":"2026-02-20","current":54.893728,"twenty":44.79956,"median":58.576126,"eighty":72.595053,"marketCap":82398522177},{"date":"2026-02-27","current":52.350133,"twenty":44.938454,"median":58.531174,"eighty":72.112603,"marketCap":79442239320},{"date":"2026-03-06","current":49.767005,"twenty":45.116803,"median":58.469542,"eighty":72.01889,"marketCap":74913465582},{"date":"2026-03-13","current":45.00506,"twenty":45.116803,"median":58.377121,"eighty":71.985255,"marketCap":68057405340},{"date":"2026-03-20","current":44.215816,"twenty":45.114658,"median":58.350601,"eighty":71.8872,"marketCap":66610713729},{"date":"2026-03-27","current":44.200592,"twenty":44.738431,"median":58.251953,"eighty":71.510989,"marketCap":74095770324},{"date":"2026-04-01","current":45.969918,"twenty":44.673253,"median":58.208228,"eighty":71.283766,"marketCap":77618149898}],"updateTime":1775125501143},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02268\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2616306232","title":"大摩：藥明合聯(02268)股價未來30日將絕對上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2616306232","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616306232?lang=zh_tw&edition=fundamental","pubTime":"2026-03-03 17:27","pubTimestamp":1772530053,"startTime":"0","endTime":"0","summary":"该行给予药明合联目标价为86港元，其评级为“增持”。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20260303/20260303172831_42715.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260303/20260303172831_42715.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409501.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["SG9999014674.SGD","LU2488822045.USD","02268","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616596093","title":"醫藥行業跟蹤報告：中國創新ADC閃耀ASCO GU，長效三靶點減肥藥二期臨床成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2616596093","media":"爱建证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616596093?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 22:06","pubTimestamp":1772460407,"startTime":"0","endTime":"0","summary":"投资要点：医药板块行情复盘：本周为春节假期后第一周，市场温和反弹，沪深300指数+1.08%，但A股医药板块整体表现平淡，SW医药生物指数+0.50%，在申万一级行业指数中排名25/31。中国创新ADC闪耀ASCOGU，映恩DB-1311生存获益数据优异。联邦三靶点减肥药UBT251二期临床成功，将尽快启动三期临床研究。2月24日，联邦制药发布公告，其自主研发的长效GLP-1/GIP/GCG三靶点激动剂UBT251注射液已完成在中国超重/肥胖患者中的二期临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302220654a699592f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302220654a699592f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","03933","BK1191","09926","02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616318201","title":"每日沽空追蹤 | 藥明合聯 03月02日沽空量成交30.3萬股，沽空比例為6.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616318201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616318201?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 16:30","pubTimestamp":1772440232,"startTime":"0","endTime":"0","summary":"药明合联北京时间03月02日，跌2.77%，卖空量成交30.3万股，较上一交易日减少69.64%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163437a730c74d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163437a730c74d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02268","SG9999014674.SGD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616538865","title":"【券商聚焦】招銀國際：AI將改變創新藥物研發範式","url":"https://stock-news.laohu8.com/highlight/detail?id=2616538865","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616538865?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 14:40","pubTimestamp":1772433633,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，MSCI中国医疗指数2026年初至今累计上涨5.0%，跑赢MSCI中国指数6.2%。医药行业近期明显回调（MSCI中国医疗指数1月15日至今累计下跌9%），特别是创新药板块回调幅度较大（恒生生物科技指数1月15日至今累计下跌13%）。该机构认为，此轮调整原因包括博弈层面行业短期缺乏催化剂，以及行业轮动导致资金流出医药板块。中国创新药资产出海BD持续超预期，MNC对于中国资产的购买范围从单个管线拓宽至平台合作，进一步体现了中国创新药的竞争力。该机构认为，中国的AI制药技术发展迅猛，将涌现一批优秀的创新企业。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975709","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348735423.USD","BK1515","01530","01789","IE00BPRC5H50.USD","159992","LU1303224171.USD","LU2476274720.SGD","BK1617","LU0640798160.USD","LU1969619763.USD","BK1197","02228","LU0348825331.USD","LU2328871848.SGD","02367","03933","LU2399975544.HKD","LU0348783233.USD","BK1141","BK1583","02268","BK1161","BK1585","LU1251922891.USD","BK1207","LU1720050803.USD","LU1115378108.SGD","SG9999004311.SGD","LU1961090484.USD","02196","LU0348784397.USD","06978","09926","01099","IE00B543WZ88.USD","LU0348827113.USD","LU2488822045.USD","BK1574","LU0307460666.USD","09688","LU1794554557.SGD","LU0588546209.SGD","LU0634319403.HKD","SG9999014674.SGD","LU0561508036.HKD","HK0000165453.HKD","06160","BK1100","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616800129","title":"《大行》交銀國際：藥明合聯(02268.HK)全球CXO賽道投融資、BD交易延續高活躍度 維持「買入」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2616800129","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616800129?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 14:09","pubTimestamp":1772431740,"startTime":"0","endTime":"0","summary":"交银国际研究报告指出，药明合联作为反映CRDMO业务需求的先行指标，全球CXO赛道的投融资和BD交易在2026年初延续了过去两年的极高活跃度。交银国际的目标价为91港元，对应2026年市盈率42倍，维持“买入”评级，考虑到公司在高景气度的XDC CRDMO赛道中稳居全球领先地位、当前投资性价比极高，继续将公司选为CXO行业重点推荐标的。沽空资料截至 2026-03-02 12:25。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20231117104105862_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20231117104105862_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1505890/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1505890/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616580103","title":"《大行》大摩：藥明合聯(02268.HK)股價未來30日將絕對上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2616580103","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616580103?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 11:58","pubTimestamp":1772423880,"startTime":"0","endTime":"0","summary":"摩根士丹利发表技术意见报告，相信药明合联(02268.HK) 股价在未来30日将绝对上涨，主要是该股近期交易价格下跌，令短期估值更具吸引力。药明康德宣布一项涉及其有效载荷连接子技术平台的规模可观的对外授权协议。此类协议包括预付款、里程碑付款以及潜在的销售分成，这些都将有助于提升销售额和盈利能力。该行给予药明合联目标价为86元，其评级为“增持”。(ca/w)(港股报价延迟最少十五分钟。沽空资料截至 2026-02-27 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20231117104101799_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20231117104101799_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1505845/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1505845/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","02268","LU2488822045.USD","SG9999014674.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193991119","title":"藥明合聯與Earendil Labs就Wuxitecan-2有效載荷-連接子技術平台達成戰略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1193991119","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193991119?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 17:14","pubTimestamp":1772183652,"startTime":"0","endTime":"0","summary":"药明合联（WuXi XDC）宣布与Earendil Labs建立战略合作伙伴关系，双方将围绕Wuxitecan-2有效载荷-连接子技术平台展开深度协作。此次合作旨在整合彼此在生物偶联技术领域的优势资源，共同推进新型抗体偶联药物（ADC）技术的开发与应用。\n通过本次战略联手，药明合联将借助Earendil Labs在创新有效载荷-连接子技术方面的专长，进一步拓展其ADC技术平台的能力边界。Wuxitecan-2作为新一代拓扑异构酶I抑制剂有效载荷，具有显著的治疗潜力，这项合作将加速其在癌症治疗领域的创新应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","SG9999014674.SGD","02268","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614154831","title":"藥明合聯與Earendil Labs就WuXiTecan-2載荷連接子技術授權達成戰略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2614154831","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614154831?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 17:11","pubTimestamp":1772183460,"startTime":"0","endTime":"0","summary":"上海2026年2月27日 /美通社/ -- 全球领先的专注于提供抗体偶联药物等生物偶联药物端到端CRDMO服务的药明合联，今日宣布与Earendil Labs就药明合联自主研发的WuXiTecan-2载荷连接子技术授权达成战略合作。Earendil Labs利用其独特的AI平台生成了具有差异化优势的双特异性抗体，与我们的WuXiTecan-2载荷连接子技术联用，有望开发出更有效、更安全的下一代ADC药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4897609_ZH97609_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["02268","LU2488822045.USD","SG9999014674.SGD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614045007","title":"藥明合聯午前漲近8% 公司有望持續受益XDC CRDMO行業下游需求改善趨勢","url":"https://stock-news.laohu8.com/highlight/detail?id=2614045007","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614045007?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 11:55","pubTimestamp":1772164500,"startTime":"0","endTime":"0","summary":"　　药明合联盘中涨超8%，截至发稿，股价上涨7.54%，现报62.75港元，成交额3.01亿港元。2024年年初以来，XDC领域投融资事件数、BD交易数和首付款总额呈逐步上升态势。投融资和BD交易持续活跃，将进一步拉动XDC CRDMO行业下游需求改善，药明合联作为技术实力和一体化交付能力布局的龙头企业，有望持续受益于这一重要趋势、并扩大市场份额。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-02-27/doc-inhpfnzn6798937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1141","02268","LU2488822045.USD","SG9999014674.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614009267","title":"【券商聚焦】交銀國際：2026年醫藥板塊穩中向好態勢或將延續 但仍有短期波動可能","url":"https://stock-news.laohu8.com/highlight/detail?id=2614009267","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614009267?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 09:45","pubTimestamp":1772156713,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，本周2026ASCOGU大会常规摘要公布，此次大会将于本月2628号召开，共有超过70项我国专家主导的研究入选，荣昌、翰森、科伦博泰、映恩生物等中国创新药企将携重磅数据亮相，临床数据密集释放有望阶段性催化板块行情。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975588","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2476274308.USD","LU1720050803.USD","LU2778985437.USD","LU1794554557.SGD","BK1100","01099","01789","LU1770034418.SGD","LU0348766576.USD","LU0417516571.SGD","159938","02268","BK1141","02367","BK1207","06160","BK1617","03329","BK1515","BK1197","LU1251922891.USD","LU0348784397.USD","HK0000165453.HKD","BK1161","01530","LU0348827113.USD","LU0417516902.SGD","LU1961090484.USD","09688","LU0588546209.SGD","LU0640798160.USD","09926","LU0417516738.SGD","BK1588","LU2399975544.HKD","02196","02228","LU0348767384.USD","LU0634319403.HKD","LU2476274720.SGD","LU2488822045.USD","IE00BPRC5H50.USD","LU0348825331.USD","03933","SG9999014674.SGD","09939","BK1191","LU0540923850.HKD","BK1147","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614697009","title":"【券商聚焦】交銀國際維持藥明合聯(02268)買入評級 指XDC賽道融資/BD開年延續較高熱情","url":"https://stock-news.laohu8.com/highlight/detail?id=2614697009","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614697009?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 09:43","pubTimestamp":1772156610,"startTime":"0","endTime":"0","summary":"2024年年初以来，XDC领域投融资事件数、BD交易数和首付款总额呈逐步上升态势。投融资和BD交易持续活跃，将进一步拉动XDC CRDMO行业下游需求改善，药明合联作为技术实力和一体化交付能力布局的龙头企业，有望持续受益于这一重要趋势、并扩大市场份额。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975587","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128119023","title":"港股創新藥概念股走強！藥明合聯升逾7%，雲頂新耀、再鼎醫藥漲近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128119023","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128119023?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 09:40","pubTimestamp":1772156400,"startTime":"0","endTime":"0","summary":"2月27日，港股创新药概念股走强，$药明合联(02268)$涨超7%，$云顶新耀(01952)$、$再鼎医药(ZLAB)$涨近6%，$康方生物(09926)$、$药明生物(02269)$涨超4%，$歌礼制药-B(01672)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9a5adfc15d956a00313fe91052a1cff8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VT","BK1574","BK4588","09688","01952","BK4139","BK1588","BK4585","ZLAB","VXUS","BK1161","BK4531","SG9999014674.SGD","BK4548","06978","BK1583","BK1141","LU2488822045.USD","159992","02268","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614567008","title":"藥明合聯02月26日主力淨流出958.1萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2614567008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614567008?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 16:15","pubTimestamp":1772093752,"startTime":"0","endTime":"0","summary":"02月26日, 药明合联股价跌8.69%，报收58.35元，成交金额5.0亿元，换手率0.66%，振幅10.41%，量比3.95。药明合联今日主力资金净流出958.1万元，上一交易日主力净流入335.0万元。该股近5个交易日下跌10.08%，主力资金累计净流出1675.2万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出5857.5万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226162012a4caa49b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226162012a4caa49b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","BK1141","LU2488822045.USD","02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614008526","title":"藥明合聯盤中異動 大幅跳水5.01%報60.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614008526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614008526?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 14:06","pubTimestamp":1772085973,"startTime":"0","endTime":"0","summary":"2026年02月26日下午盘14时06分，药明合联股票出现波动，股价大幅下挫5.01%。截至发稿，该股报60.700港元/股，成交量429.846万股，换手率0.34%，振幅5.71%。资金方面，该股资金流入9895.07万港元，流出1.2869亿港元。药明合联股票所在的生物技术行业中，整体跌幅为3.94%。其相关个股中，百奥赛图-B、药捷安康-B、思路迪医药股份涨幅较大，振幅较大的相关个股有三叶草生物-B、百奥赛图-B、药捷安康-B，振幅分别为11.96%、11.38%、9.90%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226140613a4ca28ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226140613a4ca28ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","BK1141","SG9999014674.SGD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614081032","title":"每日沽空追蹤 | 藥明合聯 02月25日沽空量成交32.9萬股，沽空比例為16.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614081032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614081032?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 16:30","pubTimestamp":1772008232,"startTime":"0","endTime":"0","summary":"药明合联北京时间02月25日，跌1.01%，卖空量成交32.9万股，较上一交易日减少68.23%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163414a71d5a7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163414a71d5a7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","LU2488822045.USD","SG9999014674.SGD","02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613875532","title":"每日沽空追蹤 | 藥明合聯 02月23日沽空量成交11.3萬股，沽空比例為10.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613875532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613875532?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 16:30","pubTimestamp":1771835429,"startTime":"0","endTime":"0","summary":"药明合联北京时间02月23日，涨2.21%，卖空量成交11.3万股，较上一交易日减少65.96%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163343a4be7d73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163343a4be7d73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","LU2488822045.USD","02268","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613204910","title":"【國聯民生醫藥】醫藥周報20260223：春節期間醫藥行業重點事件梳理","url":"https://stock-news.laohu8.com/highlight/detail?id=2613204910","media":"医耀科技创新骑手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613204910?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 14:18","pubTimestamp":1771827529,"startTime":"0","endTime":"0","summary":"1春节期间医药行业重点事件梳理1.1创新药BD交易实现开门红，优势产品海外研发和注册进展顺利2026年春节前后，中国创新药对外BD交易实现开门红，全年交易金额有望再攀新高。根据医药魔方，截至2026年2月15日，中国创新药2026年对外BD交易首付款规模超过2025年任一季度，总金额超过2025年全年水平的1/3。3）2月17日，石药集团发布公告，SYH2082的临床试验申请获得FDA批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223142808a71517c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223142808a71517c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01801","03759","09995","09606","02228","01456","BK1515","02268","06938","01530","BK1161","02155","09939","02252","BK1564","BK1147","02359","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612581462","title":"《大行》大摩降藥明合聯(02268.HK)目標價至86元  評級「增持」","url":"https://stock-news.laohu8.com/highlight/detail?id=2612581462","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612581462?lang=zh_tw&edition=fundamental","pubTime":"2026-02-20 10:19","pubTimestamp":1771553940,"startTime":"0","endTime":"0","summary":"摩根士丹利发表研究报告指出，鉴于药明合联(02268.HK) 早前披露2025年初步业绩，因经营利润率下降，该行将其2026至2030年盈利预测下调1%至2%，目标价亦相应下调2%，由88元降至86元。此外，该行预测药明合联2024至2027年的经调整净利润的年均复合增长率达36%，远高于全球同业，予其“增持”评级，看好公司盈利增长及可见性较高、毛利扩张潜力，以及行业领导地位。(jl/u)(港股报价延迟最少十五分钟。沽空资料截至 2026-02-16 12:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20231117104104222_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20231117104104222_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1503868/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1503868/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612230586","title":"藥明合聯(02268)出現大手賣出11.95萬股，成交價$64.95，涉資776.152萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2612230586","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612230586?lang=zh_tw&edition=fundamental","pubTime":"2026-02-20 09:35","pubTimestamp":1771551300,"startTime":"0","endTime":"0","summary":"[大手成交]药明合联(02268)在上午09:35出现大手卖出，成交量为11.95万，成交价为港币$64.95，涉资776.152万。至目前为止，股价无升跌，今日最高价为$66.15，而最低价为$64.95，总成交量为22.25万股，总成交金额港币$1.446千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145549237_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145549237_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2602201007/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2602201007/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2488822045.USD","02268","BK1141","SG9999014674.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612847734","title":"藥明合聯02月16日遭主力拋售211.9萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612847734","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612847734?lang=zh_tw&edition=fundamental","pubTime":"2026-02-16 16:15","pubTimestamp":1771229731,"startTime":"0","endTime":"0","summary":"02月16日, 药明合联股价跌0.46%，报收65.00元，成交金额5556.5万元，换手率0.07%，振幅2.45%，量比0.20。药明合联今日主力资金净流出211.9万元，上一交易日主力净流出960.0万元。该股近5个交易日上涨3.59%，主力资金累计净流出1103.1万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出2520.9万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216161642a700d466&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216161642a700d466&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02268","BK1141","SG9999014674.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}